Skip Baldino has over 35 years in the healthcare industry. Just prior to his role at EndoGastric Solutions (EGS), he served four years as President, Americas for Given Imaging-a world leader in GI medical devices, offering healthcare providers a range of innovative options for visualizing, diagnosing and monitoring the digestive system. Covidien completed its acquisition of Given Imaging in February 2014 in an $860 million deal (Medtronic now acquired Covidien). Prior to Given Imaging, he enjoyed a distinguished 26-year career at Abbott Laboratories-a worldwide diversified health care company. While there, Mr. Baldino established an outstanding track record of consistent and high-performing financial and organizational success. His experience encompasses various key customer segments, as well as a wide range of product portfolios, product life-cycles, new product launches, and integrations. As a divisional Vice President, he held key commercial leadership roles in: Diabetes Care, Diagnostics, Medical Products (Corporate), Hospital Products (now known as Hospira), Health Systems, and Specialty Products.

Mr. Baldino graduated with a bachelor’s degree in Marketing from Philadelphia University.

Mr. Baldino was also the Chairman of the Board of ACell, a regenerative medicine company that was focused on the development, manufacturing, and commercialization of medical devices for wound management and surgical soft tissue repair. He served on ACell’s board from 2015 until their January 2021 sale to Integra Health Sciences valued up to $400 million, including a $300M upfront payment.